Inpharma Weekly

, Volume 1542, Issue 1, pp 12–12 | Cite as

Deferred bicalutamide effective in hormone-refractory prostate cancer

Clinical study
  • 4 Downloads

Keywords

Prostate Cancer Androgen Prostate Specific Antigen Doubling Time Specific Antigen 

Copyright information

© Adis International Ltd 2006

Personalised recommendations